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Abstract 
THE IMPACT OF ADOLESCENT NICOTINE EXPOSURE ON DRUG DEPENDENCE IN 
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Major Director: M. Imad Damaj, Ph.D  
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Nicotine is one of the first and most commonly abused drugs in 
adolescence. According to The Center for Disease Control, every day more than 
6000 adolescents try their first cigarette and over 3000 of them become daily 
smokers. Smoking among adolescents is a strong predictor of future drug abuse 
and dependence in adulthood. A number of studies has suggests that 
adolescents pre-exposed to nicotine may suffer permanent disruption of the 
brain’s reward systems through changes in dopamine receptor function. We 
hypothesize that nicotine exposure during adolescence causes long lasting 
neurobiological alterations that increase the likelihood of cocaine use in 
adulthood. Furthermore, it activates a neurobiological mechanism that is shared 
by many drugs of abuse, which will increase susceptibility to their rewarding 
effects. The work in this thesis contributes to the further understanding of this 
critical developmental period. Conditioned-place-preference, acute locomotor and 
locomotor sensitization pardigms were used to examine changes in cocaine 
sensitivity in adulthood. Testing was performed on adult ICR mice that were 
 
  
vii
exposed to nicotine (0.1 or 0.5 mg/kg, S.C., b.i.d.) or saline during adolescence 
(postnatal days 28 or 46) or adult (postnatal day 70). Data showed that a 7-day  
exposure to the higher dose of nicotine (0.5 mg/kg) altered cocaine-induced 
responses. In contrast, neither 1 day exposure nor a low dose of nicotine (0.1 
mg/kg) elicited this effect. A follow-up study was undertaken to determine if this 
enhancement generally applies to other drugs of abuse. Pre-exposure to 
0.5mg/kg nicotine during early adolescence demonstrated significant 
enhancement to morphine reward, but it failed to increase d-amphetamine 
preference in a CPP model. Further research will be required in order to more 
fully examine the mechanisms of action for the observed changes in cocaine 
rewards. In summary, these findings suggest that early adolescent nicotine 
exposure leads to changes in cocaine reward and sensitivity during adulthood in 
both dose and duration matters. Indeed, the adolescent brain is uniquely 
vulnerable to the effects of nicotine on subsequent drug reward.  
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Introduction 
1.1. Adolescent development: 
Adolescence, defined as approximately ages 12 to 18 in humans and 28 to 
60 postnatal days in mice and rats, is the final developmental period leading to 
adulthood (Spear, 2000). During this critical period a transition occurs from a 
fully-dependent child to an independent adult. This transition involves many 
changes in a variety of areas, such as physical growth, cognition, social skills, 
physiology, and emotions.  This development maturation allows the individual to 
reach independence from parental care. Adolescence is generally associated with 
puberty (sexual maturation). However, puberty can be exactly defined in 
physiological terms; adolescence boundaries are less precisely defined and 
include both psychological and social factors (Laviola, 2003). Furthermore, 
adolescence stage is defined by certain behavioral changes observed in this time 
frame including increases in social interaction, risk-taking and novelty or reward 
seeking. These changes are universal across a variety of species (Spear, 2000). 
Indeed, over fifty percent of adolescents exhibit an increase in risk-taking 
behaviors such as novel experiences involving drugs, alcohol and sexual activity. 
Usually, risky behavior is viewed as exciting and rewarding (Arnett 1992). Similar 
to humans, adolescent mice have shown hyperactive behavior in novel 
environments (Darmani et al., 1996).  
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1.2. Adolescent Brain development: 
The adolescent brain is unique and in a state of transition as it undergoes 
marked maturation that may play a role in subsequent drug abuse (Spear 2000). 
An adolescent brain is anatomically and neurochemically different from that of an 
adult brain. The adult male brain is approximately 10% larger than an adolescent 
brain. Human MRI images have shown a linear increase in white matter and an 
inverted U-shaped change in gray matter volume. Consequent to gray matter, 
the synaptic connections increased during the early adolescent and rapidly 
pruned back in late adolescence (Giedd, 2004).  The adolescent brain goes 
through an increase in myelination and synaptic pruning to allow more efficient 
neural signaling. It has been predictable that as many as 50% of the average 
number of synapses are lost during adolescence. This appears to be associated 
with the marked maturation. One reason for synapse elimination is to decrease 
unnecessary excitatory stimuli to the brain since many of the synapses in 
adolescence are excitatory (Rakic et al. 1994). Moreover, the adolescent brain 
shows remarkable alterations in neurochemical transmission. Distinctively, the 
mesocorticolimbic dopamine system goes through significant modeling during 
adolescent periods .The balance between mesocortical and mesolimbic dopamine 
systems varies across a variety of species (Spear 2000). These developments are 
responsible for the integration of the external environment with internal drives to 
produce motivated behavior (Chambers et al., 2003).The prefrontal cortex (PFC) 
Volume decline is in humans (Sowell et al. 1999) and rats (Van Eden et al. 1990). 
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Moreover, density of spines on pyramidal cells in the human PFC decline (Mrzljak 
et al. 1990). Dopaminergic innervation of the prefrontal cortex increases in 
density during adolescence peak at levels well above those seen earlier or later 
in life (Lewis 1997; Brenhouse et al. 2008). Also, the DA transporters number 
increase (Akbari et al. 1992).There is also a transient increase in the number of 
DA receptors that has been reported (Seeman et al. 1987). In spite of that, 
transformations of neural circuitry are not limited to the DA system, these 
changes are thought to play a critical role in the rewarding and reinforcing 
effects of many drugs of abuse, including nicotine and cocaine. These various 
studies suggest that adolescence is a unique period of intense neurological 
development, and many of the changes that are ongoing during this period may 
contribute to a heightened susceptibility to substance abuse. 
1.3. Adolescent Drug Use: 
The age of adolescence is often the time for novelty seeking and risk 
taking behaviors. It is also during this period that they are introduced to the 
world of tobacco, alcohol, and illicit drugs. According to the National Survey on 
Drug Use and Health (2007), about 2.8 million children, aged 12 and above have 
tried illicit drugs for the first time. In fact, in 2006, the number of cocaine 
initiates, or those who have tasted cocaine for the first time, reached about 918 
adolescents a day (NSDUH, 2007). Based on epidemiological studies, adolescents 
who are exposed to tobacco and alcohol at an early age are most likely to use 
illicit drugs later on in their lives (Kandel and Logan, 1984). Furthermore, those 
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who started at an early age have a harder time quitting, thus leading to a 
heavier consumption of illicit drugs, tobacco and alcohol (Breslau and Peterson, 
1996). Individuals under the age of 15 who smoke cigarettes are eighty times 
more likely to use illegal drugs as compared to those who don’t (Breslau and 
Peterson, 1996). Epidemiological studies have lead to the hypothesis that 
nicotine may serve as a “gateway” drug that leads to an increased likelihood of 
dependence on other drugs (Kandel et al ,1992). Animal studies have been 
conducted to evaluate the "gateway" theory, since it allows for a more controlled 
experiment and can identify the underlying mechanism for the progression of 
drug use. In contrast, epidemiological studies in humans have been unable to 
control factors such as environment, genetics, and others that confound the 
analysis.  
When an adolescent is exposed to nicotine at an early age, it leads to a 
neurochemical alteration that may persist into adulthood, thus enhancing further 
the need to smoke (Adriani et al., 2003). In fact, changes in the 
mesocorticolimbic dopaminergic signaling due to illicit drug use at an early age 
can increase a person’s vulnerability to other classes of abused drugs (Trauth et 
al., 2001). 
1.4. Adolescent Smoking: 
The long-term impact of tobacco use in adolescence is documented. 90% 
of adult smokers report their first use of tobacco prior to age 18 (Chassin et al. 
1990).  Another study found that students who have tried a single cigarette by 
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age 11 remain vulnerable to future smoking, up to 3 years later (Fidler et al. 
2006). Over 6,000 teenagers begin smoking every day (American Lung 
Association Statistics 2002). Initiating smoking during adolescence correlates 
with greater addiction liability, higher daily consumption, and reduced likelihood 
of quitting (Colby et al. 2000; Kandel and Chen 2000). Indeed, an adolescent 
smoking only two to four cigarettes per week is at risk of becoming addicted in 
early adulthood (Riggs et al. 2007). Among American adolescents the number of 
smokers has been rising sharply since 1992, while the age of initiation for 
smoking has been declining (Johnston et al. 1998). Nicotine, the primary 
addictive component in tobacco, acts on the brain to produce both rewarding 
and aversive effects (Castane et al. 2005). Many adolescents become dependent 
on nicotine despite the fact that initial exposure to nicotine has been shown to 
be unpleasant (Eissenberg and Balster 2000). Despite the fact that nicotine 
reaches the brain rapidly, it does not have long lasting acute effects; the short 
half-life of nicotine of only 1 to 2 hours is likely to contribute to its repeated and 
consistent use (Viveros et al. 2006). Adolescent smoking is different than adult 
smoking and occurs in stages. The average number of cigarettes smoked per day 
is 5.2 among adolescent smokers aged 12 to 17(NHSDA ,2003). Adolescent 
smokers also experience signs of withdrawal such as cravings, nervousness, and 
the inability to concentrate (Rojas et al. 1998; Killen et al. 2001). Indeed, this 
group of teenagers reports frequent unsuccessful attempts to quit due to 
cravings and withdrawal symptoms (Johnson 1982; Biglan and Lichtenstein 
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1984). Without a doubt, factors such as social pressure, environment, stress, 
biological effects, reinforcing effects, and aversive withdrawal symptoms 
contribute to an adolescent’s decision to maintain a regular level of smoking.  
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Hypothesis 
We hypothesize that nicotine exposure during adolescence causes long 
lasting neurobiological alterations that increase the susceptibility to cocaine 
reward in adulthood. Furthermore, it will activate a neurobiological mechanism 
that is shared by many drugs of abuse, which will increase susceptibility to their 
rewarding effects. 
Dissertation Objectives 
The research in this thesis focuses on the effects impact of adolescent 
nicotine exposure on the subsequent behavioral of cocaine.  Based on 
preliminary data and previous literature, we hypothesized that adolescent who 
are exposed to low doses of nicotine would demonstrate increased vulnerability 
to cocaine reward as compared to adults.  Our first specific aim was to 
characterize the impact of the effects of nicotine exposure during adolescence 
with regards to cocaine. Both dose and duration of nicotine exposure were 
investigated. Rewarding effects, changes in locomotor activity and locomotor 
sensitization to cocaine were evaluated. The second and final specific aim was to 
examine whether adolescent nicotine exposure effect generalizes to other 
typically-abused drugs such as morphine and amphetamine.  
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Materials and Methods 
2.1. Subjects 
Experimentally, naïve male adolescents and adult ICR mice were 
purchased from Harlan Laboratories (Indianapolis, IN.). ICR mice are an out-
bred strain which have been used extensively in pharmacological studies. 
Adolescent animals were obtained from different litters to avoid any effects that 
may have confounded the result. Adolescent mice have been classified by the 
use of three age intervals, early adolescence (PND 28-to-34), middle adolescence 
(PND 34-to-46), and late adolescence (PND 47-to-59), (Spear 2000; Laviola 
2003). These divisions are based on the similarities in physical, sociological, and 
biological development in both rodents and humans. These divisions have been 
carefully assessed in rodents and are assumed to correlate well with aspects of 
human adolescence.  For all studies, adolescent mice arrived on postnatal day 
(PND) 21 and weighed approximately 18-23 grams at the start of the 
experiment; adult mice arrived on PND 65 and weighed approximately 30-35 
grams. The animals were housed in groups of four mice per cage, and allowed to 
acclimate for seven days, the cages had small houses and toys. The mice were 
handled for three days prior to the experiment with unlimited access to food and 
water, except during the experimental sessions. All mice were housed in a 
humidity and temperature controlled (22 °C) vivarium on a 12-hr light/dark cycle 
(lights on at 6 a.m., off at 6 p.m.). Testing was conducted during the light phase 
of the  cycle. At the end of each experiment, the animals were euthanized by 
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way of CO2 inhalation. Animals were maintained in a facility approved by the 
American Association for Accreditation of Laboratory Animal Care, and all 
procedures were approved by the Institutional Animal Care and Use Committee 
of Virginia Commonwealth University.  
2.2. Drugs 
The drugs used in these experiments were (−)-Nicotine hydrogen tartrate 
salt[(−)-1-methyl-2-(3-pyridyl)pyrrolidine (+)-bitartrate salt] and  mecamylamine 
hydrochloride [2-(methylamino) isocamphane hydrochloride], purchased from 
Sigma-Aldrich Inc. (St. Louis, MO, USA); and d-amphetamine, morphine and 
cocaine HCl, obtained from the Drug Supply Program of the National Institute on 
Drug Abuse (Rockville, MD). All drugs were dissolved in 0.9% sterile saline 
(0.9% sodium chloride) and prepared fresh before each experiment. All 
compounds were injected subcutaneously (s.c.) except for the cocaine, which 
was injected intraperitoneally (i.p.) at a volume of 10 ml/kg body weight. Doses 
are expressed as the free base of the drug. Control groups received saline 
injections at the same volume and by the same route.   
2.3. Injection Protocol  
Mice received nicotine during early adolescence (PND 28), middle 
adolescence (PND 34), late adolescence (PND 47), or adulthood (PND 70+). 
Based on previous work done by our lab, we choose to use either a short pattern 
(one day) or a long pattern (7 days) of exposure. Depending upon the 
experiment conducted, nicotine (0.1 and 0.5 mg/kg), cocaine (10 mg/kg), or 
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saline was administered twice daily, with injections approximately 6 hours apart 
(8 a.m. and 2 p.m.). After treatment, the adolescent mice were kept in their 
home cages for 42 days to allow them to reach adulthood, at which point they 
were evaluated in paradigms as described below. Adult mice were kept for 
similar time periods as the adolescent mice.  
2.4. Conditioned Place Preference 
Conditioned place preference is a method which has been used widely to 
evaluate the rewarding effects of a drug by pairing a drug with a particular 
context (Bardo et al. 1995; Tzschentke 1998). Place conditioning boxes consisted 
of two equal-sized compartments (20 cm long x 20 cm wide x 20 cm high), 
separated by a grey central area with an opening that allowed access to either 
side of the chamber. The opening in the partition could be closed off for pairing 
days. The compartments have different-colored walls (one black, one white) and 
distinct floor textures (grid rod floor in the black compartment and mesh in the 
white one). The CPP protocol was conducted over the course of five days in an 
unbiased fashion. The CPP procedure consisted of three phases: an initial 
preference test, three conditioning days, and a final preference test. Animals 
showing great initial preferences for one of the compartments were eliminated 
from the study, because it is difficult to detect a shift in time spent in a 
compartment when an animal had a strong initial bias prior to conditioning. This 
is particularly important for drugs such as nicotine, which has a weak reinforcing 
property. 
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Handling habituation: On Friday through Sunday of the week prior to the start of 
the place-conditioning procedure, mice in the CPP studies were handled once per 
day for approximately two minutes each. Previous work done by our lab 
demonstrated that handling experience plays an important role in the ability of 
nicotine to produce a conditioned place preference (Grabus et al. 2006).  
On day one: An initial preference test; animals were placed in the boxes and 
allowed to roam freely from side to side for 15 minutes. Time spent in each side 
was recorded using Med Associates interface and software. These data were 
used to separate the animals into groups of approximately equal bias.  
On day 2-4: Conditioning phase animals were paired for 20 minutes, the saline 
group received saline on both sides of the boxes.  Depending on the experiment, 
the drug groups received nicotine, cocaine, morphine or d-amphetamines  on 
one  side and saline on the opposite side of the boxes. Drug paired sides were 
randomized among all groups. Conditioning lasted for three days, with animals in 
the drug group receiving drugs each day.  
On day 5: The final preference test was administered, no injections were given. 
Animals were placed in the boxes and allowed to roam freely from side to side 
for 15 minutes. The time spent on each side was recorded, and the data were 
calculated based on time spent on the drug paired side minus time spent on the 
saline paired side. An increase in time spent in the initially favored compartment 
was indicated as a preference for the drug paired side, while a reduction or 
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negative number indicated an aversion (CPA) to the drug paired side. A number 
at or near zero indicated no partiality for either side.      
2.5. Acute Locomotor Activity: 
Pretreated mice were placed into individual Omnitech photocell activity 
cages, (Columbus, OH; 28 x 16.5 cm), 10 minutes after the i.p. administration of 
cocaine. Interruptions of the photocell beams, which assess walking and rearing, 
were then recorded for the next 30 minutes. Data were computed as the number 
of photocell interruptions. 
2.6. Cocaine Locomotor Sensitization: 
In this study, only early adolescent mice (PND 28) were used. Mice were 
pretreated at adolescence with saline or nicotine (0.5 mg/kg) s.c. injections twice 
daily for seven days; the injections were approximately six hours apart.  Our 
protocol was based on the study completed by Biala, (2003). Once the mice 
reached PND 70, a 13 day cocaine sensitization procedure was launched.    
On Day 1: Mice received a saline injection (i.p.) and were then placed in 
locomotor activity chambers for a 30 minute habituation period while activity 
counts were recorded. Immediately the mice were removed from the locomotor 
boxes and randomly divided into three groups: saline-saline, saline-cocaine, and 
cocaine-cocaine (the group names represent the acquisition-day drug, followed 
by the challenge day drug). The mice were then given another injection of either 
saline or cocaine 20 mg/kg (i.p.), depending on their assigned group, and placed 
in the chambers again for a 30-minute acquisition period. 
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Days 2–5: The mice received an i.p. injection of either saline or cocaine 20 
mg/kg, depending on their assigned group, and placed in the chambers again for 
a 30-minute acquisition period. 
Days 6–12: A drug-free week; the animals received no injections or exposure to 
the chambers. 
Day 13: Challenge day; the mice were tested again in the same way as described 
for days 1–5, but the cocaine mice received a challenge-dose of cocaine of 5 
mg/kg (i.p.). Counts were recorded for a 30-minute test period. 
2.7. Statistical analysis  
For all data, statistical analyses were performed using StatView ® (SAS, 
Cary, NC, USA). Statistical analysis of all behavioral studies was performed with 
mixed-factor ANOVA with post-hoc Tukey’s test when appropriate. P-values of 
less than 0.05 were considered to be statistically significant. 
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Studies 
3.1 Methods 
3.1.1. The Effect of Adolescent Nicotine Exposure on Cocaine-Induced 
Conditioned Place Preference 
 
Early adolescent mice (PND 28) and adults were divided into two groups. 
One group received a short (1-day) nicotine exposure protocol, while the other 
group received a long (7-day) protocol. Furthermore, each group was subdivided, 
eight animals to each group. Two dose of nicotine were tested (0.1 or 0.5 mg/kg, 
s.c.) As a control, adult ICR mice (PND=70) received the same treatment 
protocol as the adolescents. When the adolescent mice reached young adulthood 
(PND 70), and again at PND 112, they were tested for cocaine reward using 
conditioned place preference. As previously described, mice have an initial 
preference phase which is a drug-free assessment of baseline preference in a 
three-compartment chamber. This is followed by a conditioning phase, which 
includes three days of conditioning to cocaine (10 mg/kg i.p.). After the 
conditioning period, the last day of the paradigm is the final preference phase, 
during which preference is assessed. Preference scores are expressed as time 
spent on the drug-paired side minus time spent on the saline-paired side. A 
positive number indicated a preference for the drug-paired side, while a negative 
number indicated an aversion to the drug-paired side. A number at or near zero 
indicated no preference for either side. 
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3.1.2. Influence of the Age of Nicotine Exposure on the Enhancement of Cocaine 
Reward 
 
Only late adolescent mice (PND 47) were used in this study. Mice were 
injected with either nicotine (0.5 mg/kg s.c.) or saline twice a day for one week, 
then put in their cages to reach adulthood. Once the adolescent mice had 
reached PND 89, they were tested for cocaine reward using conditioned place 
preference. 
3.1.3. To Determine the Onset of the Cocaine Enhancement 
For this study we used only early adolescent (PND 28) mice. The mice 
were injected with either 0.5mg/kg nicotine or saline twice daily for a week. At 
PND 36, the mice were tested for cocaine preference (10mg/kg, i.p.) as 
described previously. Separate groups of mice received the same pretreatment 
protocol and were tested for cocaine CPP at late adolescence (PND 50). 
3.1.4. To Determine the Impact of the Sequential Order between Nicotine and 
Cocaine 
  
Early adolescent mice (PND 28) received cocaine (10mg/kg i.p.) or saline 
twice daily for a week. Once adolescent mice had reached adulthood (PND 70), 
they were tested for nicotine (0.5mg/kg s.c.) reward using conditioned place 
preference. 
3.1.5. To Determine if the Enhancement of Cocaine Reward by Nicotine is 
Receptor –Mediated 
 
 Male ICR mice (PND 28) were randomly divided into groups: saline-saline, 
mecamylamine-saline, mecamylamine-nicotine and saline-nicotine (groups 
represent the first treatment followed by the second treatment). Depending on 
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the group, mice were injected with mecamylamine (2mg/kg s.c.—a dose well 
known to block most behavioral effects of nicotine in rodents), nicotine (0.5 
mg/kg s.c.), or saline. At adulthood (PND 70), mice were tested for cocaine (10 
mg/kg i.p.) reward using CPP animal model 
3.1.6 Effect of Adolescent Nicotine Exposure on Morphine and Amphetamin-
Induced Conditioned Place Preference 
 
To determine whether the early adolescent nicotine pretreatment effect 
generalizes to other illicit drugs, adolescents, aged postnatal day 28, were given 
two daily injections of saline or nicotine (0.5 mg/kg, s.c.). At PND 70, mice were 
tested with a morphine (5mg/kg s.c.) reward, and another group were tested 
with amphetamine (5mg/kg s.c) reward using conditioned place preference. 
3. 1.7. Effects of Adolescent Nicotine Exposure on Cocaine-Induced Hyperactivity 
Mice were tested for cocaine-induced hyperactivity using locomotor 
chambers after reaching adulthood. For this study, early adolescent (PND 28) 
and adult (PND 70) ICR male mice received 0.5 mg/kg nicotine or saline s.c. 
injection twice daily for 7 days, with injections approximately 6 hours apart. On 
PND 70 and 112 respectively, Mice were injected i.p with either saline or various 
doses of cocaine (5, 10, and 20 mg/kg) and then placed into individual Omnitech 
photocell activity cages (Columbus, OH; 28 x 16.5 cm) 10 minutes after injection. 
Interruptions of the photocell beams, which assess walking and rearing, were 
then recorded for the next 10 minutes. The data are expressed as the number of 
photocell interruptions. 
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3.2. RESULTS 
3.2.1 Effect of Adolescent Nicotine Exposure on Cocaine-Induced Conditioned 
Place Preference 
 
Figures 1 and 2 show cocaine-induced CPP in nicotine pretreated mice 
over all stages of adolescence and adulthood. It was important first to determine 
the dose and length of nicotine exposure that is required to produce cocaine 
enhancement in adulthood. Figures 1-a and 1-b show respectively the mice that 
received either a short 1-day, or long 7-day exposure to nicotine during early 
adolescence. All mice conditioned with cocaine in the CPP model developed 
significant preference for the cocaine-paired side when compared to their 
respective saline controls. An overall two-way ANOVA (pretreatment x exposure 
duration) showed that only mice that had a 7-day exposure to the higher dose of 
nicotine (0.5 mg/kg) displayed a significantly enhanced level of preference, 
compared to those mice pretreated with saline. Interestingly, the short exposure 
to nicotine failed to produce a significant enhancement of cocaine when 
compared to the saline pretreated mice, even with the higher dose of nicotine.  
Next, we wanted to determine the influence of the age of nicotine 
exposure on the enhancement of cocaine reward. In Figure 1 and 2, age 
differences were seen when cocaine was given (two-way ANOVA: age × 
pretreatment), with only early adolescents exhibiting greater preference in 
response to 10 mg/kg of cocaine based on pretreatment status (shown in Figure 
1-b). The results of cocaine-induced CPP following late adolescent and adult 
nicotine exposure are shown in Figures 2-a and 2-b respectively. Neither late 
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adolescent nor adult mice displayed any significant differences based on 
pretreatment status in a 7-day exposure protocol.  
Also, it was important to determine the onset of this enhancement. 
Results from Figure 3-a and b show that significant enhancement peak in mice 
tested in CPP model at PND 50 and continue to PND 70 (two-way ANOVA: age × 
pretreatment).In contrast, mice tested for cocaine-induce reward at PND 35 
displayed approximately equal levels of preference for cocaine despite varying 
pretreatment groups.  
Moreover, we wanted to determine the impact of the sequential order 
between nicotine and cocaine. Mice were pretreated with various dose of cocaine 
(10 or 20 mg/kg) in early adolescence and conditioned with nicotine in the CPP 
model in the adulthood. Results revealed that nicotine produced significant 
preference in saline pretreated mice compare to saline control. On the other 
hand, 10 and 20 mg/kg cocaine pre-exposure in adolescent mice demonstrated 
no nicotine preference compared to saline pretreated mice (fig. 4). 
 Finally, determining if the enhancement of cocaine rewards or nicotine 
rewards is receptor-mediated was a priority. Figure 5 shows that enhancement in 
pretreated nicotine mice disappeared when mice received mecamylamine before 
nicotine. Theses data suggest that early adolescence is the most critical stage for 
cocaine-induced rewarding effects, and that this enhancement is affected by 
dose and duration of nicotine exposure. 
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Figure 1. Effects of early adolescent nicotine exposure on cocaine-induced CPP 
in adulthood (a) 1-day (two injections) (b)7-day(14 injection).The y-axis 
represents preference score and the x-axis expresses adolescent treatment in the 
CPP paradigm. Each bar represents the mean ± SEM of seven to eight mice.      
* p<.05 from respective saline control; # p<.05 from salaine-cocaine 
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Figure 2. Effect of late adolescent and adulthood nicotine exposure on cocaine-
induced reward. The y-axis represents preference score and the x-axis expresses 
adolescent treatment in the CPP paradigm. A frequent pattern (7-day) of nicotine 
exposure in late adolescence (a) and adulthood (b) was tested. Each bar represents 
the mean ± SEM of eight mice. *p < 0.05 from respective saline control.  
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Figure 3. The Onset of the Cocaine Enhancement. The y-axis represents 
preference score and the x-axis expresses adolescent treatment followed by 
treatment in the CPP paradigm. a. CPP at early adolescence. b. CPP at late 
adolescence . * p<.05 from respective saline control; # p<.05 from saline-
cocaine group in the same graph.  
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Figure 4. The Effects of early adolescent cocaine exposure on nicotine-induced 
CPA in adulthood. The y-axis represents preference score and the x-axis 
expresses adolescent treatment in the CPP paradigm. Each bar represents the 
mean ± SEM of seven to eight mice. *p<.05 from respective saline control;       
# p<.05 from saline-nicotine. 
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Figure 5. The Effects of early adolescent mecamylamine-nicotine exposure (7-
day) on cocaine-induced CPP in adulthood. The y-axis represents preference 
score and the x-axis expresses adolescent treatment in the CPP paradigm. Each 
bar represents the mean ± SEM of seven to eight mice.* p<.05 from respective 
saline control; # p<.05 from saline-cocaine. 
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3.2.2 Effect of Adolescent Nicotine Exposure on Morphine and Amphetamin-
Induced Conditioned Place Preference 
 
Figure 6, shows that all mice, which were conditioned with morphine or 
amphetamine in the CPP model, developed significant preference for the drug-
paired side as compared to their respective saline controls. Interestingly, mice 
which were pretreated with nicotine during adolescence and had morphine in 
adulthood displayed a significantly enhanced level of preference as compared to 
those mice which were pretreated with saline. In contrast to the morphine data, 
the amphetamine (5 mg/kg) did not produce a significant enhancement of 
reward.  
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Figure 6. Effects of early adolescent nicotine exposure on morphine and 
amphetamine-induced CPP in adulthood (a) morphine (b) amphetamine. The y-
axis represents preference score and the x-axis expresses adolescent treatment 
in the CPP paradigm. Each bar represents the mean ± SEM of seven to eight 
mice.  * p<.05 from respective saline control; # p<.05 from saline-morphine. 
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3.3.3. Effects of Adolescent Nicotine Exposure on Cocaine-Induced Hyperactivity  
In this study, we examined the effects of early adolescent exposure to low 
doses of nicotine (0.5mg/kg) on cocaine’s acute effects, using a locomotor 
activity test.  Figures 7 and 8 show the results of these studies. All age groups 
displayed a dose-responsive increase in locomotor activity in when given cocaine. 
No significant changes were observed after the short (one day) or long (seven 
day) nicotine exposure protocol during early adolescence as compared to those 
pretreated with saline. Figures 8-a and 8-b show the results from studies where 
pretreatment occurred in adulthood. The results were the same, no significant 
differences were seen based on the adult group that received pretreatment.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 27
 
a. 
 
 
 
 
 
 
 
 
b. 
 
 
 
 
 
 
 
Figure 7. Cocaine-induced hyperactivity following nicotine exposure in early 
adolescence. Mice were pretreated with saline or nicotine during early 
adolescence either acutely (1 day) or repeatedly (7 days) and were tested for 
cocaine hyperactivity in adulthood. n=6/group . 
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Figure 8. Cocaine-induced hyperactivity following nicotine exposure in Adulthood 
Mice were pretreated with saline or nicotine during early adolescence either 
acutely (1 day) or repeatedly (7 days) and were tested for cocaine hyperactivity 
in adulthood. n=6/group. 
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3.3.4 Effects of Adolescent Nicotine Exposure on Locomotor Sensitization to 
Cocaine  
 
In Figure 9, mice that received low doses of nicotine in adolescence are 
depicted with solid bars while the mice pretreated with saline  are displayed with 
non-solid bars. During the acquisition period, mice that were treated with 
cocaine (20 mg/kg) showed an increase in locomotor activity, as expected, with 
no differences due to adolescent pretreatment (*p<.05 as compared to sal-sal). 
On challenge day, two groups received an injection of cocaine i.p. (5 mg/kg). 
Mice pretreated with both saline and nicotine and mice  treated with cocaine, 
during acquisition, displayed an enhanced locomotor activity compared to  mice 
treated with saline only. However, mice that were pretreated with nicotine in 
adolescence demonstrated a significant increase in cocaine-induced locomotor 
activity in comparison to the animals pretreated with saline. These results 
established that we were able to induce locomotor sensitization to cocaine, and 
that early adolescent nicotine exposure enhances this effect. 
On challenge day two groups received an injection of cocaine i.p. (5 mg/kg). 
Both saline and nicotine pretreated mice who were treated with cocaine during 
acquisition displayed enhanced locomotor activity as compared to those mice 
treated with saline during acquisition. However, mice which were pretreated with 
nicotine in adolescence demonstrate a significant increase in cocaine-induced 
locomotor activity as compared to saline pretreated animals. These results 
established that we were able to induce locomotor sensitization to cocaine and 
that early adolescent nicotine exposure enhances this effect. 
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Figure 9. Cocaine-sensitization in ICR male mice. Early adolescent mice were 
pretreated with either saline (non-solid bars) or nicotine (solid bars) for 7 days 
and were tested for cocaine-induced locomotor sensitization in adulthood. 
Treatment groups are represented by acquisition drug-challenge drug in the 
legend (ex. sal-coc = saline during acquisition and cocaine on challenge day) 
*p<.05 from sal-sal control on the same day; # p<.05 from sal-coc group; 
$p<.05 from saline pretreated coc-coc group.(done by Dena Kota)            
                                                            
 
 
 
 
 
 
 
 31
Discussion 
We hypothesized that adolescent nicotine exposure causes long-lasting 
neurobiological alterations that increase susceptibility to cocaine use in adulthood. 
Furthermore, by activating a neurobiological mechanism shared by many 
commonly abused drugs, the effect of pre-exposure to nicotine during 
adolescence may enhance rewards derived from a variety of other substances, 
which in turn may increase susceptibility to abuse these drugs. 
The present study of nicotine use in adolescence finds that exposure to 
nicotine enhances the experienced reward of cocaine, but this is dependent on 
the dose ,the duration of nicotine exposure and the age of the subject. Our data 
showed that a 7-day  exposure to (0.5 mg/kg) nicotine during early adolescent 
was able to alter cocaine-induced responses.  In contrast, neither a 1-day 
exposure nor a lower dose of nicotine (0.1 mg/kg) was able to elicit this effect. 
This suggests that a more chronic pattern of adolescent nicotine exposure is 
required to induce lasting changes in subsequent behavioral responses. Since 
data in our first experiment suggested early adolescence was a critical period for 
nicotine reward, we decided to focus on this phase of development for 
subsequent studies. Similar to the effects seen with reward, exposure of early 
adolescent mice to nicotine also enhanced locomotor sensitization to cocaine in 
adulthood. However, an enhancement of cocaine-induced hyperactivity did not 
occur upon acute  or chronic injection of the drug in early adolescent and adult 
mice pre-treated with nicotine.  
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This differential enhancement of cocaine’s behavioral effects suggests that 
nicotine exposure in adolescence has an impact only on long-term 
neuroadaptations after chronic/repeated administration to nicotine.  Our data 
strongly suggest that nicotine intake during adolescence may act to cross-
sensitize the brain to cocaine’s long-term changes in the brain.   
 Many drugs of abuse share reward circuitry in the brain: the 
mesocorticolimbic reward pathway, which has been implicated in many of the 
rewarding and reinforcing effects of drugs of abuse (Nestler 2001; Kobb and Le 
Moal 2001). This pathway originates in the ventral tegmental area and sends 
projections to the nucleus accumbens (NAc) (Nestler 2001; Hyman and Malenka 
2001). In fact, animals with lesions in these regions demonstrate a loss of drug 
utilization (Robinson and Berridge 2001; Nestler 2004). Dopamine is the most 
common and essential neurotransmitter involved in this pathway.  
Azam et al. (2007) report that nicotine-stimulated dopamine release is 
significantly higher during the early adolescent period in the male rat. Nicotine, 
in particular, is able to activate VTA dopaminergic neurons directly via 
stimulation of nicotinic cholinergic receptors, or indirectly via stimulation of its 
receptors on glutamatergic neurons, which then innervate dopamine cells. Early-
adolescent nicotine exposure significantly elevates nAChR function in adulthood 
(Kota 2009). Repeated stimulation by nicotine may promote maturation and 
facilitate cocaine-induced plasticity of the mesocorticolimbic system. Our results 
show that nicotine-induced enhancement of cocaine’s effects is mediated by 
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neuronal nicotine receptors since mecamylamine, a nicotinic receptor antagonist, 
blocked the enhancement. It is not clear which specific nicotinic subtypes are 
blocked, because mecamylamine is a non-selective antagonist. Our data suggest 
that the high preference of cocaine following nicotine pretreatment results from 
activation of neuronal nicotinic receptors during the pretreatment phase, because 
the enhancement “portion’’ of cocaine preference was blocked .  
 It is also clear from our results that the animals’ age of exposure has a 
great impact. Indeed, nicotine exposure in early, but not late, adolescence 
enhanced cocaine’s rewarding effects, suggesting that early adolescence is a 
critical period for the behavioral plasticity induced by nicotine. Furthermore, 
control animals receiving nicotine during adulthood did not show enhancement of 
cocaine’s rewarding effects.   
 Finally, cross-sensitization to the rewarding effects of cocaine in the CPP 
after nicotine pre-exposure was observed in late adolescence and continued to 
adult age.  Although the time-course of this enhancement was not fully 
determined, our results suggest that the behavioral plasticity observed is long 
and may well extend beyond PND 70.   
We have used an intermittent pattern of nicotine exposure over a brief 
period (7-days), and a low dose of nicotine (0.5 mg/kg) that is known to produce 
CPP. These protocols were selected in order to mimic patterns of adolescent 
experimentation with cigarette smoking, namely short/acute and intermittent 
exposure.  The dose was administered by subcutaneous injection, which more 
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closely mimics early teenage smoking. The pattern of adolescent smoking is 
different to that of adults, as it occurs in stages. It usually involves repeated, 
albeit irregular, use over an extended period. This ranges from 3 to 5 cigarettes 
per week in an irregular manner for occasional and experimental smokers, to 3 
to 5 cigarettes per week, every week, for regular smokers who might later move 
to a state of nicotine dependence. In fact, some youths will advance to 
dependence before leaving high school. The smoking pattern in adolescence is 
further complicated by the fact that it is affected by specific events, such as 
parties and weekends. Therefore, mimicking the human pattern of nicotine 
exposure in an adolescent mouse model is not an easy task, since the 
adolescence period in rodents is very short. We therefore chose a low dose 
regimen (0.1 and 0.5mg/kg) and an intermittent pattern of nicotine exposure 
over a short period (7-days) for our studies. Subcutaneous injection better 
reflects the intermittent pattern of nicotine administration. Although oral 
administration (nicotine in drinking water) of nicotine is stress free, the 
absorption of nicotine is affected by the first pass metabolism, which leads to 
variable absorption. For our studies, we have attempted to mimic the amount of 
nicotine that an adolescent is exposed to daily, which is an equivalent of 5.2 
cigarettes. A dose of 0.5 mg/kg of nicotine is comparable to the amount of 
nicotine inhaled from smoking two to four cigarettes, (Benowitz N.L. ,1990).  
Our data agree with a study conducted using rats where the investigators 
utilized intravenous pre-treatments containing low doses of nicotine in 
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adolescents over a four-day period, (McQuown, 2007). This nicotine exposure 
resulted in an enhanced cocaine-sensitization response. Similarly, rats given 
nicotine at PND 35 for 10 days showed an enhancement of cocaine-induced 
reward using a CPP paradigm, (McMillen et al., 2005). Similar to our data on 
cocaine sensitization, it has recently been shown that exposure to nicotine in 
adolescent rats for seven days led to an enhanced sensitization to cocaine; as 
opposed to those exposed only to saline,  (McQuown, 2009).  
In contrast, another study found that C57BL/6J mice demonstrated a 
decline in cocaine-induced preferences, as measured by CPP after 25 days of 
nicotine exposure in adolescents, (Kelley and Rowan, 2004). This inconsistency 
could be due to the difference in mouse strain, C57BL/6J vs. ICR, as well as the 
length of time of exposure. In addition, it was found that nicotine pre-exposure 
led to an increase in cocaine’s motor activating effects, whereas our data 
demonstrates no change in the acute locomotor study. Research has shown 
mixed results regarding the effect of cocaine rewarding properties from nicotine 
exposure in adolescents as compared to that of adults. It is clear that a number 
of factors may be responsible for the differences between these studies; such as 
species, drug dosage, length of pre-exposure, and timing of the testing. Since 
any of the variables, or a combination thereof, may be responsible for the 
difference in results; more work needs to be done to establish how the long-term 
effects of adolescent nicotine exposure may be affected by these variables. 
  Exposure to nicotine during this period of brain development may lead to 
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persistent, long lasting changes in the brain. Furthermore, the enhancement in 
cocaine reward may be replicated with other drugs of abuse. A study done by 
Kota et al. suggested early adolescent nicotine exposure significantly elevates 
the nAChR function in adulthood in the brain. Indeed, pre-exposure to 0.5mg/kg 
nicotine during early adolescence demonstrated significant enhancement to the 
morphine’s reward, but it failed to increase d-amphetamine preference in a CPP 
model (fig.6). Adolescent nicotine exposure has long-lasting effects on the 
development of various pharmacological systems, specifically the dopaminergic 
system. Amphetamine, cocaine (psychostimulants), morphine (opiates), and 
nicotine (cholinergic agonists) preferentially increase synaptic dopamine 
concentrations in the mesolimbic dopaminergic system (Di Chiara G). Cocaine 
acts as an indirect dopamine agonist. It increases synaptic DA levels in the 
nucleus  accumbens via its actions at the DA transporter, inhibiting uptake into 
the presynaptic terminals (Harris and Baldessarini, 1973). Morphine, through the 
mu-opioid receptor activation, is known to excite dopamine neurons in the VTA 
by the inhibition of the GABA-ergic inhibitory interneurons and, thereby, 
increases dopamine transmission to the NAC (Rezayof et al., 2007).  
The dopaminergic pathway is a likely candidate for observed cross-
sensitization as mentioned previously; many studies have shown that illicit drugs 
tend to enhance dopamine transmission from the ventral tegmental area to the 
nucleus accumbens (Koob and Le Moal, 1997.  Dani, 2003). Also, other receptors 
may be involved in our behavioral observations. Glutamatergic receptors are 
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known to be involved in nicotinic effects as well. A study shows that adolescent, 
but not adult, nicotine exposure down-regulated mGluR2/3 subunits in the 
hippocampus and striatum. This same study also showed changes in NMDA 
NR2A/B subunits regardless of the time of exposure, suggesting the involvement 
of NMDA receptors in certain aspects of nicotine dependence (Adriani et al. 
2004). These findings imply that other receptors may also be involved and 
should be further examined.  
Surprisingly, 10 mg. of cocaine pretreatment during early adolescence 
demonstrates condition-place aversion to nicotine during adulthood. These 
results may correlate with the establishment of drug dependence and an 
increased risk of relapse after a period of withdrawal. They also further implicate 
a role for dopamine in cross-sensitization to other drugs of abuse. Taken 
together, our data suggests that adolescent nicotine exposure may cause 
molecular alterations which lead to enhanced vulnerability to drug dependence 
later in life. Preventing adolescent experimentation with tobacco is extremely 
important as it can rapidly cause persistent changes in drug-induced behavioral 
responses. 
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Future Studies 
Our findings suggest that early adolescent nicotine exposure results in 
long-lasting alterations in behavioral response to cocaine and other drugs of 
abuse in adulthood. The rewarding effects of cocaine and morphine are elevated 
in a dose- and duration-dependent manner. In our studies, relatively low levels 
of nicotine and short patterns of exposure during early adolescence resulted in 
long-lasting changes in the rewarding properties of cocaine and morphine. Our 
data imply that the adolescent brain is uniquely vulnerable to the effects of 
nicotine on subsequent drug reward. Even short periods of exposure to cigarette 
smoking, which are often seen in the adolescent population, could have long-
lasting and detrimental effects on smoking  and drug abuse behavior.  
Although drugs of abuse target several brain areas, enhanced dopamine 
transmission from the ventral tegmental area (VTA) to the nucleus accumbens 
(NAc) is a key element in the reward (Koob and Le Moal 1997; Dani 2003). It is 
known that adolescent nicotine exposure has long-lasting effects on the 
development of various pharmacological systems, and it is likely that the 
dopaminergic system is one that is greatly affected. Since many drugs of abuse 
are known to affect levels of dopamine in the brain, this pathway is a likely 
candidate for the observed cross-sensitization. The mechanisms underlying this 
“cross-sensitization” are still being elucidated, and additional studies would be 
useful for determining these pathways. For example, nicotine may alter number 
of dopamine receptors or function or level of dopamine transporters; therefore, 
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studies measuring DA receptor function and binding of DA ligands as well as DAT 
binding should be conducted. Specifically, D1 and D2 ligands are of particular 
interest.  
These findings also raise the question of how exposure to secondhand smoke in 
adolescence may affect sensitivity to drug abuse reward. We have shown that 
relatively short periods of nicotine exposure and at low levels can cause 
alterations in important regulatory systems. Children with parents or friends who 
smoke may be exposed to levels of nicotine that can detrimentally affect the 
development of neurological systems. These changes are likely to affect the 
reinforcing and aversive properties of nicotine and other drugs of abuse and may 
lead to increased vulnerability in these areas. The effect of exposure to 
secondhand smoke on nicotine dependence in those children has yet to be 
explored, and our results could have important implications for prevention 
messages 
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